- Home
- AUUD vs PALI Comparison
AUUD vs PALI Comparison
Compare AUUD & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUUD
- PALI
- Stock Information
- Founded
- AUUD 2012
- PALI 1996
- Country
- AUUD United States
- PALI United States
- Employees
- AUUD N/A
- PALI N/A
- Industry
- AUUD Computer Software: Prepackaged Software
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUUD Technology
- PALI Health Care
- Exchange
- AUUD Nasdaq
- PALI Nasdaq
- Market Cap
- AUUD 3.8M
- PALI 4.1M
- IPO Year
- AUUD 2021
- PALI N/A
- Fundamental
- Price
- AUUD $0.70
- PALI $3.57
- Analyst Decision
- AUUD Hold
- PALI Strong Buy
- Analyst Count
- AUUD 1
- PALI 1
- Target Price
- AUUD N/A
- PALI $22.50
- AVG Volume (30 Days)
- AUUD 175.0K
- PALI 20.5K
- Earning Date
- AUUD 11-12-2024
- PALI 11-08-2024
- Dividend Yield
- AUUD N/A
- PALI N/A
- EPS Growth
- AUUD N/A
- PALI N/A
- EPS
- AUUD N/A
- PALI N/A
- Revenue
- AUUD N/A
- PALI N/A
- Revenue This Year
- AUUD N/A
- PALI N/A
- Revenue Next Year
- AUUD N/A
- PALI N/A
- P/E Ratio
- AUUD N/A
- PALI N/A
- Revenue Growth
- AUUD N/A
- PALI N/A
- 52 Week Low
- AUUD $0.54
- PALI $3.14
- 52 Week High
- AUUD $11.75
- PALI $22.35
- Technical
- Relative Strength Index (RSI)
- AUUD 50.20
- PALI 50.95
- Support Level
- AUUD $0.54
- PALI $3.16
- Resistance Level
- AUUD $0.63
- PALI $3.81
- Average True Range (ATR)
- AUUD 0.05
- PALI 0.21
- MACD
- AUUD 0.02
- PALI 0.03
- Stochastic Oscillator
- AUUD 80.98
- PALI 63.08
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products include Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.